Strengths

Liquidity is solid with a 2.61 current ratio and 2.01 quick ratio, giving NCI more near-term flexibility than more levered peers.

Debt-to-equity of 0.82 is manageable versus highly levered competitors, limiting refinancing pressure despite weaker earnings quality.

The company still converts working capital into cash, but a 55.9-day cash conversion cycle is only average relative to stronger operators.

NCI’s capital structure is less strained than peers with heavier leverage, yet negative ROIC shows the balance-sheet cushion is not translating into superior returns.

Weaknesses

TTM ROIC of -0.6% indicates NCI is destroying value on invested capital, lagging peers that generate positive spread returns.

Net debt to EBITDA of 5.37x is elevated, leaving NCI more exposed than better-capitalized peers to earnings volatility and higher funding costs.

A 55.9-day cash conversion cycle ties up working capital longer than efficient peers, reducing flexibility and pressuring free cash generation.

The absence of disclosed margin data alongside negative returns suggests weaker operating efficiency than peers with clearer margin resilience.

Opportunities

If management improves working-capital discipline, NCI can release cash faster than peers with similar inventory and receivables intensity.

Deleveraging from the current 5.37x net debt to EBITDA would materially improve peer positioning by lowering financial risk and expanding strategic flexibility.

Operational turnaround that restores positive ROIC would narrow the gap with stronger peers and improve long-term capital allocation credibility.

With liquidity currently adequate, NCI has room to prioritize balance-sheet repair before peers facing tighter short-term funding constraints.

Threats

High leverage leaves NCI more vulnerable than peers to rate pressure and covenant stress if earnings remain weak or cyclical demand softens.

Negative ROIC increases the risk that capital deployed today will underperform peers, compounding relative value destruction over the next several years.

A prolonged cash conversion cycle can force heavier external financing needs than more efficient competitors, especially if working capital expands.

Without margin disclosure, peers with clearer cost advantages may continue to outcompete NCI on pricing power and earnings durability.

Overall Score

NCI’s structural position versus peers is weak because negative returns and elevated leverage outweigh adequate liquidity and leave limited evidence of durable competitive advantage.